| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.2 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.2 |